Research Calls
- Upgrades:
- American Equity Investment Life (AEL) upgraded to Strong Buy from Outperform at Raymond James; tgt $48
- Enphase Energy (ENPH) upgraded to Outperform from Market Perform at Northland Capital; tgt $365
- Glaukos (GKOS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $42
- Moderna (MRNA) upgraded to Buy from Hold at Jefferies; tgt raised to $275
- Pentair (PNR) upgraded to Buy from Hold at Stifel
- PerkinElmer (PKI) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $170
- Verizon (VZ) upgraded to Market Perform from Underperform at MoffettNathanson; tgt $41
- Downgrades:
- Ameriprise Financial (AMP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $325
- AT&T (T) downgraded to Underperform from Market Perform at MoffettNathanson; tgt $17
- AXIS Capital (AXS) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $60
- Baxter (BAX) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $55
- Catalent (CTLT) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
- L3Harris (LHX) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $241
- Louisiana-Pacific (LPX) downgraded to Hold from Buy at TD Securities; tgt $72
- Tesla (TSLA) downgraded to Perform from Outperform at Oppenheimer
- Vertex Pharma (VRTX) downgraded to Hold from Buy at Jefferies; tgt $340
- VTEX (VTEX) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $5
- Xylem (XYL) downgraded to Hold from Buy at Stifel; tgt raised to $115
- Others:
- Annaly Capital Mgmt (NLY) initiated with a Buy at Jones Trading; tgt $22.50
- Bank of Montreal (BMO) resumed with an Outperform at Credit Suisse
- DZS Inc. (DZSI) initiated with an Outperform at Cowen; tgt $25
- F&G Annuities & Life (FG) initiated with an Equal Weight at Barclays; tgt $22
- Main Street Capital (MAIN) initiated with a Neutral at UBS; tgt $40
- MasterBrand (MBC) initiated with a Hold at Loop Capital; tgt $9
- NewAmsterdam Pharma (NAMS) initiated with a Buy at Jefferies; tgt $24
- NewAmsterdam Pharma (NAMS) initiated with an Outperform at William Blair
- Schrodinger (SDGR) initiated with a Neutral at Goldman; tgt $23
- Thomson Reuters (TRI) assumed with a Sector Perform at Scotiabank; tgt $126
- VersaBank (VBNK) assumed with an Outperform at Raymond James; tgt $9
- Viridian Therapeutics (VRDN) initiated with an Outperform at Cowen; tgt $45